Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.
Ziakas
Panayiotis D
PD
D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics* / Q000378:metabolism*; D010649:Phenylalanine / Q000235:genetics / Q000378:metabolism; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000145:classification / Q000201:enzymology* / Q000235:genetics*; D013922:Thrombocytosis / Q000201:enzymology* / Q000235:genetics; D013927:Thrombosis / Q000201:enzymology* / Q000235:genetics*; D035501:Uncertainty; D014633:Valine / Q000235:genetics / Q000378:metabolism
D010649:Phenylalanine; D053614:Janus Kinase 2; D014633:Valine